| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.002 |